Shandong Xinhua Pharmaceutical Company Limited (0719.HK)
HKD 5.78
(0.0%)
HKD 5.78
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.32 Billion CNY | 17.39% |
| 2022 | 2.03 Billion CNY | 14.87% |
| 2021 | 1.77 Billion CNY | -2.26% |
| 2020 | 1.81 Billion CNY | -3.2% |
| 2019 | 1.87 Billion CNY | 20.31% |
| 2018 | 1.55 Billion CNY | 22.88% |
| 2017 | 1.26 Billion CNY | 26.64% |
| 2016 | 1 Billion CNY | 19.69% |
| 2015 | 836.64 Million CNY | 13.86% |
| 2014 | 734.82 Million CNY | 43.14% |
| 2013 | 513.36 Million CNY | -2.09% |
| 2012 | 524.31 Million CNY | -3.96% |
| 2011 | 545.94 Million CNY | 13.61% |
| 2010 | 480.54 Million CNY | 8.11% |
| 2009 | 444.49 Million CNY | 51.84% |
| 2008 | 292.74 Million CNY | 2.88% |
| 2007 | 284.56 Million CNY | -3.83% |
| 2006 | 295.89 Million CNY | -1.91% |
| 2005 | 301.64 Million CNY | 23.3% |
| 2004 | 244.64 Million CNY | -18.68% |
| 2003 | 300.85 Million CNY | -4.47% |
| 2002 | 314.92 Million CNY | -5.29% |
| 2001 | 332.51 Million CNY | 7.58% |
| 2000 | 309.07 Million CNY | 13.03% |
| 1999 | 273.43 Million CNY | 9.86% |
| 1998 | 248.89 Million CNY | 20.58% |
| 1997 | 206.41 Million CNY | 0.03% |
| 1996 | 206.35 Million CNY | 64.9% |
| 1995 | 125.14 Million CNY | -11.81% |
| 1994 | 141.89 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 397.7 Million CNY | -21.34% |
| 2024 Q1 | 678.96 Million CNY | 35.37% |
| 2024 Q2 | 505.58 Million CNY | -25.54% |
| 2023 Q4 | 501.57 Million CNY | 0.54% |
| 2023 Q2 | 562.88 Million CNY | -32.05% |
| 2023 FY | 2.39 Billion CNY | 17.39% |
| 2023 Q3 | 498.9 Million CNY | -11.37% |
| 2023 Q1 | 828.34 Million CNY | 34.01% |
| 2022 Q1 | 500.75 Million CNY | 29.02% |
| 2022 Q4 | 618.11 Million CNY | 32.51% |
| 2022 Q3 | 466.45 Million CNY | 3.19% |
| 2022 FY | 2.03 Billion CNY | 14.87% |
| 2022 Q2 | 452.01 Million CNY | -9.73% |
| 2021 Q3 | 345.53 Million CNY | -34.3% |
| 2021 Q1 | 514.09 Million CNY | 9.59% |
| 2021 Q2 | 525.91 Million CNY | 2.3% |
| 2021 Q4 | 388.12 Million CNY | 12.32% |
| 2021 FY | 1.77 Billion CNY | -2.26% |
| 2020 Q4 | 469.12 Million CNY | 10.76% |
| 2020 Q1 | 483.51 Million CNY | -1.37% |
| 2020 FY | 1.81 Billion CNY | -3.2% |
| 2020 Q3 | 423.53 Million CNY | -3.4% |
| 2020 Q2 | 438.43 Million CNY | -9.32% |
| 2019 Q2 | 452.29 Million CNY | -13.17% |
| 2019 FY | 1.87 Billion CNY | 20.31% |
| 2019 Q1 | 520.9 Million CNY | 15.17% |
| 2019 Q3 | 411.23 Million CNY | -9.08% |
| 2019 Q4 | 490.2 Million CNY | 19.2% |
| 2018 Q2 | 343.99 Million CNY | -15.0% |
| 2018 Q3 | 357.17 Million CNY | 3.83% |
| 2018 FY | 1.55 Billion CNY | 22.88% |
| 2018 Q1 | 404.72 Million CNY | 22.0% |
| 2018 Q4 | 452.29 Million CNY | 26.63% |
| 2017 Q3 | 276.31 Million CNY | -11.04% |
| 2017 Q1 | 349.44 Million CNY | 23.87% |
| 2017 Q2 | 310.61 Million CNY | -11.11% |
| 2017 FY | 1.26 Billion CNY | 26.64% |
| 2017 Q4 | 331.73 Million CNY | 20.05% |
| 2016 FY | 1 Billion CNY | 19.69% |
| 2016 Q3 | 261.47 Million CNY | 23.04% |
| 2016 Q2 | 212.51 Million CNY | -13.36% |
| 2016 Q1 | 245.28 Million CNY | 12.76% |
| 2016 Q4 | 282.1 Million CNY | 7.89% |
| 2015 FY | 836.64 Million CNY | 13.86% |
| 2015 Q1 | 230.14 Million CNY | -12.83% |
| 2015 Q4 | 217.53 Million CNY | 8.46% |
| 2015 Q3 | 200.57 Million CNY | 6.46% |
| 2015 Q2 | 188.39 Million CNY | -18.14% |
| 2014 Q3 | 154.07 Million CNY | -9.57% |
| 2014 Q4 | 264.03 Million CNY | 71.36% |
| 2014 FY | 734.82 Million CNY | 43.14% |
| 2014 Q1 | 146.33 Million CNY | 3.93% |
| 2014 Q2 | 170.37 Million CNY | 16.43% |
| 2013 Q1 | 119.27 Million CNY | 2.78% |
| 2013 Q3 | 119.17 Million CNY | -11.15% |
| 2013 FY | 513.36 Million CNY | -2.09% |
| 2013 Q4 | 140.79 Million CNY | 18.14% |
| 2013 Q2 | 134.12 Million CNY | 12.45% |
| 2012 Q3 | 134.51 Million CNY | -3.81% |
| 2012 Q2 | 139.84 Million CNY | 4.43% |
| 2012 FY | 524.31 Million CNY | -3.96% |
| 2012 Q1 | 133.91 Million CNY | -10.62% |
| 2012 Q4 | 116.04 Million CNY | -13.73% |
| 2011 Q4 | 149.81 Million CNY | 17.02% |
| 2011 Q1 | 133.57 Million CNY | 15.2% |
| 2011 Q2 | 134.53 Million CNY | 0.72% |
| 2011 Q3 | 128.02 Million CNY | -4.84% |
| 2011 FY | 545.94 Million CNY | 13.61% |
| 2010 Q3 | 113.02 Million CNY | -6.2% |
| 2010 FY | 480.54 Million CNY | 8.11% |
| 2010 Q1 | 131.07 Million CNY | 11.35% |
| 2010 Q2 | 120.49 Million CNY | -8.07% |
| 2010 Q4 | 115.94 Million CNY | 2.59% |
| 2009 Q3 | 106.46 Million CNY | 0.54% |
| 2009 Q2 | 105.88 Million CNY | -7.47% |
| 2009 FY | 444.49 Million CNY | 51.84% |
| 2009 Q1 | 114.43 Million CNY | 43.31% |
| 2009 Q4 | 117.71 Million CNY | 10.57% |
| 2008 FY | 292.74 Million CNY | 2.88% |
| 2008 Q4 | 79.85 Million CNY | 46.6% |
| 2008 Q3 | 54.46 Million CNY | -26.31% |
| 2008 Q2 | 73.91 Million CNY | -12.54% |
| 2008 Q1 | 84.51 Million CNY | 46.03% |
| 2007 Q2 | 78.8 Million CNY | -4.46% |
| 2007 Q1 | 82.48 Million CNY | 7.79% |
| 2007 FY | 284.56 Million CNY | -3.83% |
| 2007 Q4 | 57.87 Million CNY | -11.5% |
| 2007 Q3 | 65.39 Million CNY | -17.02% |
| 2006 Q4 | 76.52 Million CNY | 26.66% |
| 2006 Q3 | 60.41 Million CNY | -10.73% |
| 2006 Q2 | 67.68 Million CNY | -25.85% |
| 2006 FY | 295.89 Million CNY | -1.91% |
| 2006 Q1 | 91.27 Million CNY | 19.42% |
| 2005 Q2 | 77.11 Million CNY | -5.29% |
| 2005 Q4 | 76.43 Million CNY | 14.62% |
| 2005 Q3 | 66.68 Million CNY | -13.53% |
| 2005 FY | 301.64 Million CNY | 23.3% |
| 2005 Q1 | 81.41 Million CNY | 52.27% |
| 2004 Q3 | 46.63 Million CNY | -28.38% |
| 2004 Q1 | 79.42 Million CNY | -2.17% |
| 2004 FY | 244.64 Million CNY | -18.68% |
| 2004 Q2 | 65.11 Million CNY | -18.01% |
| 2004 Q4 | 53.46 Million CNY | 14.65% |
| 2003 FY | 300.85 Million CNY | -4.47% |
| 2003 Q3 | 53.22 Million CNY | -29.62% |
| 2003 Q2 | 75.62 Million CNY | -16.74% |
| 2003 Q1 | 90.82 Million CNY | 9.58% |
| 2003 Q4 | 81.18 Million CNY | 52.55% |
| 2002 Q2 | 75.64 Million CNY | -9.09% |
| 2002 Q1 | 83.2 Million CNY | 0.0% |
| 2002 Q3 | 73.18 Million CNY | -3.25% |
| 2002 Q4 | 82.88 Million CNY | 13.26% |
| 2002 FY | 314.92 Million CNY | -5.29% |
| 2001 FY | 332.51 Million CNY | 7.58% |
| 2000 FY | 309.07 Million CNY | 13.03% |
| 1999 FY | 273.43 Million CNY | 9.86% |
| 1998 FY | 248.89 Million CNY | 20.58% |
| 1997 FY | 206.41 Million CNY | 0.03% |
| 1996 FY | 206.35 Million CNY | 64.9% |
| 1995 FY | 125.14 Million CNY | -11.81% |
| 1994 FY | 141.89 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 167.43 Million HKD | -1286.419% |
| Grand Pharmaceutical Group Limited | 6.52 Billion HKD | 64.418% |
| Extrawell Pharmaceutical Holdings Limited | 28.77 Million HKD | -7966.175% |
| Wai Yuen Tong Medicine Holdings Limited | 394.81 Million HKD | -487.966% |
| Qianhai Health Holdings Limited | -35.6 Million HKD | 6620.137% |
| Lee's Pharmaceutical Holdings Limited | 551.31 Million HKD | -321.063% |
| Essex Bio-Technology Limited | 1.53 Billion HKD | -50.807% |
| Tongfang Kontafarma Holdings Limited | 471.29 Million HKD | -392.553% |
| PuraPharm Corporation Limited | 216.62 Million HKD | -971.585% |
| SSY Group Limited | 3.48 Billion HKD | 33.47% |
| JBM (Healthcare) Limited | 319.41 Million HKD | -626.753% |
| Jacobson Pharma Corporation Limited | 620.47 Million HKD | -274.127% |
| China Resources Pharmaceutical Group Limited | 43.36 Billion HKD | 94.647% |